- Home
- MESA vs MAIA Comparison
MESA vs MAIA Comparison
Compare MESA & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MESA
- MAIA
- Stock Information
- Founded
- MESA 1982
- MAIA 2018
- Country
- MESA United States
- MAIA United States
- Employees
- MESA N/A
- MAIA N/A
- Industry
- MESA Air Freight/Delivery Services
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- MESA Consumer Discretionary
- MAIA Health Care
- Exchange
- MESA Nasdaq
- MAIA Nasdaq
- Market Cap
- MESA 50.0M
- MAIA 56.3M
- IPO Year
- MESA 2018
- MAIA 2022
- Fundamental
- Price
- MESA $1.23
- MAIA $1.52
- Analyst Decision
- MESA
- MAIA
- Analyst Count
- MESA 0
- MAIA 0
- Target Price
- MESA N/A
- MAIA N/A
- AVG Volume (30 Days)
- MESA 90.6K
- MAIA 302.1K
- Earning Date
- MESA 08-13-2025
- MAIA 08-11-2025
- Dividend Yield
- MESA N/A
- MAIA N/A
- EPS Growth
- MESA N/A
- MAIA N/A
- EPS
- MESA N/A
- MAIA N/A
- Revenue
- MESA $406,021,000.00
- MAIA N/A
- Revenue This Year
- MESA $39.81
- MAIA N/A
- Revenue Next Year
- MESA N/A
- MAIA N/A
- P/E Ratio
- MESA N/A
- MAIA N/A
- Revenue Growth
- MESA N/A
- MAIA N/A
- 52 Week Low
- MESA $0.68
- MAIA $1.40
- 52 Week High
- MESA $1.43
- MAIA $3.74
- Technical
- Relative Strength Index (RSI)
- MESA 70.41
- MAIA 44.42
- Support Level
- MESA $1.07
- MAIA $1.50
- Resistance Level
- MESA $1.22
- MAIA $1.75
- Average True Range (ATR)
- MESA 0.04
- MAIA 0.09
- MACD
- MESA 0.01
- MAIA 0.01
- Stochastic Oscillator
- MESA 96.94
- MAIA 20.69
About MESA Mesa Air Group Inc.
Mesa Air Group Inc is a regional air carrier providing scheduled passenger service. It provides services to the District of Columbia, Canada, Cuba, and Mexico, and cargo services out of Cincinnati/Northern Kentucky International Airport. Flights are operated as American Eagle, United Express, or DHL Express flights to the terms of capacity purchase agreements with American and United and a flight services agreement with DHL. The business has a presence in domestic hubs and cities, including Dallas, Houston, Phoenix, and Washington-Dulles, and other regions.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.